Text Size
8 studies found for:    Open Studies | "Epistaxis"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Epistaxis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Conditions: Epistaxis;   Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Sodium tetradecyl sulfate (sotradecol)
2 Recruiting North American Study of Epistaxis in HHT
Conditions: Telangiectasia, Hereditary Hemorrhagic;   Epistaxis
Interventions: Drug: Sterile saline;   Drug: Bevacizumab;   Drug: Estriol;   Drug: Tranexamic Acid
3 Unknown † A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
Condition: Epistaxis
Intervention: Procedure: Nasal Cautery
4 Recruiting Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: HHT;   Morbus Osler;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: NaCl
5 Recruiting Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
6 Recruiting A Novel Anterior Rhinoscopic Scoring Scale to Predict Nasal Insertability Before Transnasal Endoscopy
Conditions: Injury Due to Endoscopic Examination;   Transnasal Endoscopy Induced Epistaxis;   Transnasal Endoscopy Induced Nasal Pain
Interventions: Procedure: anterior meatoscopy;   Procedure: Nasal sniff test
7 Recruiting Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
8 Recruiting Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
To Top

† Indicates status has not been verified in more than two years